Centre Hospitalier Universitaire Vaudois, CHUV, 1011 Lausanne, Switzerland.
Department of Internal Medicine, Sonnenhofspital, 3006 Bern, Switzerland.
Int J Environ Res Public Health. 2022 Apr 4;19(7):4325. doi: 10.3390/ijerph19074325.
The aging population and the associated demand for orthopedic surgeries are increasing health costs. Although the Diagnostic Related Groups (DRG) system was introduced to offer incentives for hospitals, concerns remain that reimbursements for older and frail patients do not cover all hospital expenses. We investigated further: (1) Does age influence net financial results in orthopedic surgery? (2) Are there patient or surgical factors that influence results? This retrospective, monocentric study compares costs and reimbursements for orthopedic patients in a tertiary care hospital in Switzerland between 2015 and 2017. The data of 1230 patients were analyzed. Overall, the net results for the hospital were positive, despite 19.5% of patients being treated at a loss. We did not find any correlation between age and profitability (p = 0.61). Patient-related factors associated with financial losses were female sex (p < 0.001) and diabetes (p = 0.013). Patients free of serious comorbidities (p = 0.012) or with a higher cost weight (p < 0.001) were more often profitable. A longer length of stay was associated with higher losses (p < 0.001). This is the first study to address the Swiss DRG reimbursement system in a broad orthopedic population, while also analyzing specific patient and surgical factors. Overall, the reimbursement system is fair, but could better account for certain interventions.
人口老龄化以及由此带来的对骨科手术的需求增加了医疗成本。尽管引入了诊断相关组(DRG)系统来为医院提供激励,但人们仍然担心对老年和体弱患者的报销费用并不涵盖所有医院费用。我们进一步调查了以下问题:(1)年龄是否会影响骨科手术的净财务结果?(2)是否有患者或手术因素会影响结果?本回顾性、单中心研究比较了瑞士一家三级护理医院 2015 年至 2017 年骨科患者的成本和报销情况。分析了 1230 名患者的数据。尽管有 19.5%的患者治疗亏损,但医院的总体净结果仍然为正。我们没有发现年龄与盈利能力之间存在任何相关性(p = 0.61)。与财务亏损相关的患者相关因素包括女性(p < 0.001)和糖尿病(p = 0.013)。没有严重合并症的患者(p = 0.012)或费用权重较高的患者(p < 0.001)更有可能盈利。住院时间延长与亏损增加相关(p < 0.001)。这是第一项在广泛的骨科人群中研究瑞士 DRG 报销系统的研究,同时还分析了特定的患者和手术因素。总体而言,报销系统是公平的,但可以更好地考虑某些干预措施。